• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX; SUPRARENAL AORTIC EXTENSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX; SUPRARENAL AORTIC EXTENSION Back to Search Results
Model Number A34-34/C80-O20
Device Problems Unintended Movement (3026); Insufficient Information (3190)
Patient Problems Aneurysm (1708); Failure of Implant (1924)
Event Date 10/26/2020
Event Type  Injury  
Manufacturer Narrative
The device involved in this event will not be returned for evaluation as it remains implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Device iteration is afx with strata.
 
Event Description
The patient was initially implanted with an afx bifurcated stent graft and a suprarenal aortic extension to treat an abdominal aortic aneurysm (aaa).Approximately eight (8) years post initial implant it was reported the graft has fallen out of the aortic neck and the aneurysm has continued to grow.Re-intervention has been planed and current patient status is doing well.
 
Event Description
The patient was initially implanted with an afx bifurcated stent graft and a suprarenal aortic extension to treat an abdominal aortic aneurysm (aaa).Approximately eight (8) years post initial implant it was reported the graft has fallen out of the aortic neck and the aneurysm has continued to grow.Re-intervention has been planed and current patient status is doing well.Additional information: a re-intervention was completed on (b)(6) 2020.The physician re-lined the existing stent grafts with an afx2 bifurcated stent graft, a vela suprarenal stent graft, a vela infrarenal stent graft and an ovation ix extender.The type 1a endoleak was resolved and the final patient status was reported to be good following a successful secondary endovascular procedure.
 
Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the sac growth of 27mm complaint is confirmed.The stent migration and type 1a endoleak event/incident were unconfirmed.Procedure-related harms, device, user, procedure, or anatomy relatedness of this complaint could not be determined with the medical records available for review.The final patient status was reported as being good following a successful secondary endovascular procedure.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Device iteration is afx with strata.Corrections: h6: device code: removed code 3026.H6: result code: remove code 3233.H6: conclusion code: remove code 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
SUPRARENAL AORTIC EXTENSION
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
MDR Report Key10863043
MDR Text Key216962320
Report Number2031527-2020-00343
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Other
Type of Report Initial,Followup
Report Date 10/26/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/18/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/31/2015
Device Model NumberA34-34/C80-O20
Device Lot Number1041865-013
Was Device Available for Evaluation? No
Date Manufacturer Received02/16/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
BIFURCATED STENT GRAFT 1032427-004; BIFURCATED STENT GRAFT (B)(4)
Patient Outcome(s) Other; Required Intervention;
Patient Age72 YR
-
-